Skip to main content
SpringerLink
Log in

Renal fibrosis rare after newer gadolinium contrast agents

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lunyera J, et al. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents. A Systematic Review. Annals of Internal Medicine : 23 Jun 2020. Available from: URL: https://doi.org/10.7326/M20-0299

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Renal fibrosis rare after newer gadolinium contrast agents. Reactions Weekly 1812, 9 (2020). https://doi.org/10.1007/s40278-020-80488-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80488-5

Search

Navigation